Eastwood Bio-Medical Canada Inc.
EBM.V
TSX
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 47.24% | 51.49% | 50.12% | -15.12% | 27.86% |
| Total Depreciation and Amortization | -75.63% | -100.00% | -100.00% | -100.00% | 60.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | 137.29% | -- | -180.88% | -- |
| Change in Net Operating Assets | 3,350.00% | -50.80% | 11.92% | 60.46% | -98.31% |
| Cash from Operations | -124.14% | -18.97% | 167.97% | 7.06% | 422.22% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 442.22% | -34.76% | -200.00% | -- | -- |
| Total Debt Repaid | -- | 59.77% | -133.66% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -178.13% | 200.00% | -139.02% | 73.91% | 138.55% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -150.82% | 80.00% | -37.14% | 356.25% | 166.30% |